CAR T cell immunotherapy (pancreatic cancer)

Chimeric antigen receptor T cell therapy · University of Pennsylvania

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CAR T cell immunotherapy (pancreatic cancer), covering 2026-01-30 to 2026-01-30. Get the full timeline:

Most recent: Clinical Trial Update: CAR T Cell Immunotherapy for Pancreatic Cancer [Phase 1]